| 摘要 |
The invention concerns the use of a compound of formula (1) in the manufacture of a medicament for the treatment or prevention of a disease or a disorder by selective action at an imidazoline receptor, and X is NR, O or S; R is hydrogen, C1 to C6 alkyl, C1 to C7 acyl, C1 to C6 alkyloxycarbonyl, C2 to C6 alkenyl, C2 to C6 alkenylcarbonyl or C2 to C6 alkenyloxycarbonyl; A is a ring forming a fused ring system with the ring containing X and is selected from (a), (b) or (c). |
